Sydney-based Omniscient Neurotechnology has received the US FDA's 510(k) clearance for its brain mapping software.
WHAT IT'S ABOUT
Quicktome is a digital brain mapping platform that provides clinicians with a visualisation of a patient's brain networks which are responsible for complex functions such as language, movement and cognition.
Featuring intuitive browser interfaces, the platform...
